Christoph Arenz researcher
Arenz, Christoph
VIAF ID: 169681305 (Personal)
Permalink: http://viaf.org/viaf/169681305
Preferred Forms
- 100 1 _ ‡a Arenz, Christoph
- 100 1 _ ‡a Arenz, Christoph
- 100 1 _ ‡a Arenz, Christoph
- 100 0 _ ‡a Christoph Arenz ‡c researcher
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
Assaying Dicer-mediated miRNA maturation by means of fluorescent substrates. | |
The cellular ceramide transport protein CERT promotes Chlamydia psittaci infection and controls bacterial sphingolipid uptake. | |
CFTR and sphingolipids mediate hypoxic pulmonary vasoconstriction | |
A chemo-enzymatic approach to specifically click-modified RNA. | |
Development of an assay for the intermembrane transfer of cholesterol by Niemann-Pick C2 protein | |
Development of carbohydrate-derived inhibitors of acid sphingomyelinase. | |
Differences and Similarities in TRAIL- and Tumor Necrosis Factor-Mediated Necroptotic Signaling in Cancer Cells | |
Differential-Mobility Spectrometry of 1-Deoxysphingosine Isomers: New Insights into the Gas Phase Structures of Ionized Lipids. | |
DNA made of purines only. | |
Elemental labelling and mass spectrometry for the specific detection of sulfenic acid groups in model peptides: a proof of concept | |
Facile synthesis of the CERT inhibitor HPA-12 and some novel derivatives | |
FRET probes for measuring sphingolipid metabolizing enzyme activity | |
Heat shock protein-based therapy as a potential candidate for treating the sphingolipidoses. | |
Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology. | |
Improved plaque assay identifies a novel anti-Chlamydia ceramide derivative with altered intracellular localization | |
Labeled chemical biology tools for investigating sphingolipid metabolism, trafficking and interaction with lipids and proteins. | |
Long endogenous dsRNAs can induce complete gene silencing in mammalian cells and primary cultures. | |
Lung endothelial Ca2+ and permeability response to platelet-activating factor is mediated by acid sphingomyelinase and transient receptor potential classical 6. | |
MicroRNA-145-targeted drug and its preventive effect on pulmonary arterial hypertension (patent WO2012153135 A1). | |
MicroRNA maturation and human disease. | |
miRNA Maturation : Methods and Protocols | |
miRNAs as novel therapeutic targets and diagnostic biomarkers for Parkinson's disease: a patent evaluation of WO2014018650. | |
Perspectives in targeting miRNA function. | |
Potent and selective inhibition of acid sphingomyelinase by bisphosphonates | |
Recent advances and novel treatments for sphingolipidoses | |
Regioselective Diazo-Transfer Reaction at the C3-Position of the 2-Desoxystreptamine Ring of Neamine Antibiotics | |
RNA Interference: Analyzing the Function of Glycoproteins and Glycosylating Proteins in Mammalian Cells | |
RNA interference: from an ancient mechanism to a state of the art therapeutic application? | |
Rolling-circle amplification: unshared advantages in miRNA detection. | |
A Scaffold-Tree-Merging Strategy for Prospective Bioactivity Annotation of γ-Pyrones | |
A series of ceramide analogs modified at the 1-position with potent activity against the intracellular growth of Chlamydia trachomatis | |
SERS and Cryo-EM Directly Reveal Different Liposome Structures during Interaction with Gold Nanoparticles | |
Small molecule inhibitors of ceramidases. | |
Sphingolipid-Transporting Proteins as Cancer Therapeutic Targets | |
Structural insights into adiponectin receptors suggest ceramidase activity. | |
Structure of a human intramembrane ceramidase explains enzymatic dysfunction found in leukodystrophy | |
Subunit composition of the mammalian serine-palmitoyltransferase defines the spectrum of straight and methyl-branched long-chain bases | |
Synthesis and biochemical investigation of scyphostatin analogues as inhibitors of neutral sphingomyelinase. | |
Synthesis and characterization of some atypical sphingoid bases | |
Synthesis of the First Selective Irreversible Inhibitor of Neutral Sphingomyelinase This work was supported by grants from the Fonds der Chemischen Industrie. C.A. is grateful to the Land of Baden-Württemberg for a scholarship from the Landesgraduie | |
Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase | |
Tsc3 regulates SPT amino acid choice in Saccharomyces cerevisiae by promoting alanine in the sphingolipid pathway |